The research project describes the components of the basic and clinical research capabilities of the University of Health Sciences/The Chicago Medical School and its potential value to the Eastern Cooperative Oncology Group. The objective of the program is to continue to provide the clinical resources of a university service which is complemented by an extensive network of community hospitals. The clinical faculty in the Medical, Surgical, Gynecological, and Radiation Oncological subspecialties interact closely with pathologists and immunologists at the Medical School and provide valuable multidisciplinary resources to ECOG. The availability of NMR scanning, E.M. and Cytogenetic laboratories added to the immunological expertise within the program provides capabilities to participate in a wide range of group activities including the testing of the role of the various immunomodifiers in cancer treatment. Data derived from important studies involving the treatment of malignant mesotheliomas and favorable non-Hodgkin's lymphomas are continuing to be analyzed and new treatment approaches devised. The University of Health Sciences/The Chicago Medical School has now developed several areas of excellence which should be of great value to the present and future activities of the Eastern Cooperative Oncology Group.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
2U10CA014144-13
Application #
3556245
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1978-06-01
Project End
1989-04-30
Budget Start
1985-06-01
Budget End
1986-04-30
Support Year
13
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Rosalind Franklin University of Medicine & Sci
Department
Type
Schools of Medicine
DUNS #
069501252
City
North Chicago
State
IL
Country
United States
Zip Code
60064
Chedid, A; Ryan, L M; Dayal, Y et al. (1999) Morphology and other prognostic factors of hepatocellular carcinoma. Arch Pathol Lab Med 123:524-8
Cummings, F J; Gray, R; Tormey, D C et al. (1993) Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death. J Clin Oncol 11:29-35
Kramer, Z B; Boros, L; Wiernik, P H et al. (1991) 13-cis-retinoic acid in the treatment of elderly patients with acute myeloid leukemia. A phase II pilot study of the Eastern Cooperative Oncology Group. Cancer 67:1484-6
Bonomi, P D; Finkelstein, D M; Ruckdeschel, J C et al. (1989) Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. J Clin Oncol 7:1602-13
O'Connell, M J; Harrington, D P; Earle, J D et al. (1988) Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage II aggressive histologic type non-Hodgkin's lymphoma. Cancer 61:1754-8
Ezdinli, E Z; Costello, W G; Kucuk, O et al. (1987) Effect of the degree of nodularity on the survival of patients with nodular lymphomas. J Clin Oncol 5:413-8
Ezdinli, E Z; Harrington, D P; Kucuk, O et al. (1987) The effect of intensive intermittent maintenance therapy in advanced low-grade non-Hodgkin's lymphoma. Cancer 60:156-60
Samson, M K; Wasser, L P; Borden, E C et al. (1987) Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. J Clin Oncol 5:86-91
Ezdinli, E Z; Kucuk, O; Chedid, A et al. (1986) Hypogammaglobulinemia and hemophagocytic syndrome associated with lymphoproliferative disorders. Cancer 57:1024-37
Ezdinli, E Z; Anderson, J R; Melvin, F et al. (1985) Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma. J Clin Oncol 3:769-75